Skip to content


  • Research article
  • Open Access

Effect of chicory seed extract on glucose tolerance test (GTT) and metabolic profile in early and late stage diabetic rats

  • 1,
  • 2,
  • 3,
  • 3,
  • 4 and
  • 1, 5Email author
DARU Journal of Pharmaceutical Sciences201220:56

  • Received: 19 July 2012
  • Accepted: 19 July 2012
  • Published:


Background and purpose of the study

The goal was to evaluate and compare the effects of aqueous extract of the seeds of chicory, Cichorium intybus L., on glucose tolerance test (GTT) and blood biochemical indices of experimentally-induced hyperglycemic rats.


Late stage and early stage of Type 2 diabetes mellitus (T2DM) were induced in rats by streptozotocin (STZ) and a combination of STZ and niacinamide (NIA/STZ), respectively. Within each group, one subgroup received daily i. p. injections of chicory extract (125 mg/kg body weight, for 28 days). Body weight and fasting blood sugar (FBS) were measured weekly. Blood was analyzed for glycosylated hemoglobin (HbA1c) and sera for alanine aminotransferase (ALT), aspartate aminotransferase (AST), nitric oxide (NO), triacylglycerol (TG), total cholesterol (TC), total protein, and insulin on days 10 and 28 after treatment. Intraperitoneal glucose tolerance test (IPGTT) along with insulin determination was performed on a different set of rats in which the chicory-treated groups received the extract for 10 days.


During 4 weeks of treatment, chicory prevented body-weight loss and decreased FBS. ALT activities and levels of TG, TC and HbA1c decreased, and concentration of NO increased in the chicory treated groups (p < 0.05). Unlike late-stage diabetes, fasting serum insulin concentrations were higher and GTT pattern approximated to normal in chicory-treated early-stage diabetic rats.


Chicory appeared to have short-term (about 2 hours, as far as GTT is concerned) and long-term (28 days, in this study) effects on diabetes. Chicory may be useful as a natural dietary supplement for slowing down the pace of diabetes progress, and delaying the development of its complications.


  • Glucose tolerance test
  • Streptozotocin
  • Niacinamide
  • Chicory
  • Hyperglycemia


The number of individuals with Type 2 diabetes mellitus (T2DM) is increasing with a rate of three new cases every ten seconds (International Diabetes Federation's 5th edition of the Diabetes Atlas, 2011); and it is being diagnosed at younger age. Multiple risk factors behind the disease include chronic stress and depression[1, 2], environmental pollutants and poisons[3], obesity and over-nutrition, and sedentary life style[4]; and the early onset may be exacerbated by Barker’s “Fetal origins of adult disease” hypothesis which calls to attention the impact on the offspring of the presence and severity of the risk factors in the pregnant mother[5].

Despite a multiplicity of drugs to affect proper blood glucose control[6], there is a tendency among the patients to seek additional remedy in traditional antidiabetic plant extracts. Medicinal plants appear to benefit diabetes in many ways[7, 8]. Cichorium intybus L., commonly known as Chicory or Kasni (among Iranian folk), has been used in traditional medicine to treat a variety of diseases including high blood sugar[911]. Whole plant ethanolic extract was reported to decrease serum glucose in rats by reducing the activity of hepatic glucose 6-phosphatase[12]. Chicoric acid from chicory and basil leaves was found to enhance insulin release by pancreatic β cells and glucose uptake by muscle cells in culture[13]. Chicory has ameliorating effects against various liver toxicities[1416] and oxidative stress[17]. Ethanolic seed extract rich in caffeoylquinic acid has recently been reported to improve glycemia in rats[18]; and a mixture of the aqueous extracts of six medicinal plants including chicory combined with stirred yoghurt filtrate was shown to protect against alloxan-induced oxidative stress and diabetes in rats[19]. However, chicory’s effects on early and late stage of diabetes have not been addressed and compared before.

Previously, we reported the effects of drinking intact chicory seed concoction on two diabetic patients. A 30% reduction in blood sugar (408 mg/dl to 286mg/dl) within one hour, and quick improvement in the state of fatigue and lethargy were observed in the patient who was on regular insulin (20 units Regular, 28 units NPH; daily) and metformin (two, daily), while it took 3 hours for the other patient who was not on drug or insulin therapy to experience the same percent decrease in blood sugar[20].

The present study was designed to investigate in more detail the differences between early and late stages of diabetes with regard to chicory’s effects on blood sugar and some other blood parameters that deviate in diabetes.

Material and methods


Chicory seeds were purchased from Bazar Bozorg Popular Market, Tehran, Iran and authenticated by Dr. Amin, a botanist of the Faculty of Pharmacy; Tehran University of Medical Sciences, with a voucher number PMP-710. STZ and NIA were purchased from Sigma (USA) and citrate buffer was obtained from Fluka (USA).

Crude extract preparation

Chicory seeds were cleaned and powdered using an electric mill. Every 200 g was soaked in 1L of distilled water and refluxed for 20 minutes in a boiling water bath to make a 20% solution. The solution was allowed to cool at room temperature before being vacuum filtered through Watman No 1 filter paper. The filtrate was lyophilized at the Department of Physiology, School of Medicine, Tehran University of Medical Sciences, without further processing and stored at −20°C; every 100 g of powdered seed yielded about 8.2 g of lyophilized substance. The crude extract was not sterilized.


All experiments were performed in the animal lab of the Faculty of Pharmacy with nine-week-old male Wistar-Albino rats weighing 200–250 g and with normal FBS levels around 86 ± 8 mg/dl. The animals were maintained in a temperature room (22 ± 2°C), with 12 h light/dark cycle and fed with standard rat chow and water ad libitum. Following several days of acclimatization, rats were randomly assigned to control and experimental groups. All ethical guidelines for use of laboratory animals were followed carefully.

The study involved three groups of rats (n = 28); one group of non-diabetic rats (Normal), and two groups of rats with diabetes; i.e., late-stage diabetic (STZ-diabetic rats), and early stage diabetic (NIA/STZ-diabetic rats). The study was ethically approved by TUMS (Tehran University of Medical Sciences) Review Board.

Experimental diabetes induction

The two models of experimental diabetes were developed in rats after overnight fasting (8 h) as follows.

Late stage (advanced) diabetes was induced by a single dose of STZ (65mg/kg body weight)[21]; this group was called the “STZ” group. Early stage diabetes, which we called “NIA/STZ” group, was developed using a combination of STZ and niacinamide (NIA) according to modified Masiello method, where, an injection of STZ (65mg/kg body weight) was followed 15 minutes later, by an injection of niacinamide (NIA) (200mg/kg body weight)[2224] in one step only. Both STZ and NIA were freshly prepared in 20 mM cold sodium citrate buffer solution (pH 4.5) and injected, intraperitoneally, with insulin needles.

Four days after injection, signs of severe and mild diabetes were detected, including bad smelling polyuria, polydipsia, aggressiveness, and restlessness. Diabetes induction was further confirmed by FBS measurement (Table 1). After confirmation of diabetes, each group was divided into, control and test, subgroups (n = 14) as shown in Table 1.
Table 1

A summary of the method: group divisions of rats, initial conditions and injections

Group name



FBS (mg/dl)

IP Chicory Injection

(Sample size)a

Non-fasting BS (mg/dl)

Weight (g)

4 days after diabetes induction

(28 days)

Control (10)

110.64 ± 5.62

200.36 ± 17.86

86.5 ± 7.17


Chicory-control (10)

104.14 ± 10.99

219.28 ± 15.42

87.64 ± 9.41



111.35 ± 7.56

228.00 ± 13.94

137.78 ± 15.62


Chicory-NIA/STZ (10)

111.28 ± 6.82

231.71 ± 14.87

137.00 ± 29.39


STZ (7)

107.93 ± 11.29

213.71 ± 21.24

308.50 ± 117.7


Chicory-STZ (10)

110.92 ± 2.59

230.28 ± 16.24

330.14 ± 109.54


BS, blood sugar; FBS, fasting blood sugar; STZ, Streptozotocin, 65 mg/kg body weight; NIA, Niacinamide, 200 mg/kg body weight,15 min later; IP, intraperitoneal;. a refers to the number of animals on day 28 after treatment.

Chicory treatment

Rats that were assigned to chicory-treated subgroups received daily i. p. injections of chicory (125 mg/kg body weight dissolved in 20-units volume of insulin syringe of normal saline) according to Pushparaj et al.[12] even though they had used whole plant ethanolic extract. The treatment started on the fifth day after induction of diabetes and lasted for 28 days. Table 1 provides a summary of group and subgroup divisions, initial weights, initial non-fasting blood sugar, and FBS after diabetes induction.

The dosage mentioned above was chosen also after a pilot experiment with limited numbers of STZ-treated rats (2 rats in two groups). Two doses of 40 and 100 mg/kg body weight were used. During 90 minute follow up of blood sugar in normally fed rats at a randomly chosen time of day (afternoon), the higher dose caused greater reduction of blood sugar. Blood sugar, (measured as explained below) decreased from 536 mg/dl down to 399 mg/dl, and from 510 mg/dl to 409 mg/dl with 100 and 40 mg/kg body weight of chicory extract, respectively. Normal saline and the previously measured quantity of the extract powder were mixed in Eppendorf tubes by a vortex mixer and injected immediately, to reduce the possibility of bacterial contamination. Despite many repeated i.p. injections, side effects, such as abdominal adhesions, were not observed in the treated rats.

Weekly measurements

FBS was determined in a drop of blood from the tail using a glucometer (ACCU-CHECK, Roche, Germany) for four successive weeks. Likewise, body weights were recorded weekly, using a Triple Beam Balance, for later analysis and in order to adjust the weights of injected chicory extract powder according to the changing body weights.

Blood sampling and analysis

Blood collection (fasting) was conducted twice: Once, 10 days after treatment with chicory, when only 4 members of each group were sacrificed; and a second time at the end of study time (28 days after the start of treatment with chicory extract) when the remaining 10 rats in each group were sacrificed. Rats were anesthetized using pentobarbital (40 mg/kg body weight dissolved in 50 ml normal saline; i. p. injection) and blood (3–4 ml) was taken from the heart. A sample (1ml) of the blood from each animal was collected in EDTA containing tubes (1.5 mg/ml) to be used for HbA1c measurement. The remaining blood samples were used to prepare sera that were stored at −80°C until used.

Fasting serum enzyme activities, ALT and AST, TG, TC and total protein concentrations in blood samples from days 10 and 28 were measured in Shariati Hospital Pathology Lab by their respective kits (from Human diagnostics, Germany) and HbA1c% was also determined by kit (RANDOX, UK), using an automatic analyzer (Hitachi 902, Japan-Germany). Insulin was determined by Rat Insulin ELISA Kit according to the manufacturer’s instructions (Mercodia, Sweden). Biochemical assay results have been presented only for the final day of study (day 28) due to similarity of the results (Table 2).
Table 2

Summary statistics of blood variables values after 28 days of i.p. chicory extract injection

Measured parameter








227.3 ± 15.2

247.6 ± 28.8

218.1 ± 21.2

242.6 ± 14.1

186.8 ± 13.7

229.9 ± 25.7


119.1 ± 20.1

128.6 ± 20.1

124.6 ± 28.6

126.0 ± 47.6

151.7 ± 64.9

103.7 ± 20.4


43.7 ± 9.9

47.4 ± 11.9

46.2 ± 7.5

40.6 ± 9.0

87.8 ± 43.0

51.2 ± 15.7


78.5 ± 31.7

83.3 ± 27.1

111.2 ± 38.1

82.8 ± 44.7

121.6 ± 26.9

97.3 ± 33.5


40.6 ± 9.9

43.0 ± 6.9

48.3 ± 7.7

51.3 ± 11.0

56.2 ± 9.6

49.6 ± 7.9

Total protein

6.10 ± 0.5

5.9 ± 0.2

6.0 ± 0.2

6.4 ± 0.6

5.8 ± 0.5

5.7 ± 0.5

HbA1caŦ,bŦ, d†,e†,fŦ

3.9 ± 0.2

3.9 ± 0.2

4.0 ± 0.4

4.0 ± 0.1

8.0 ± 2.3

6.5 ± 1.9

NOa‡, b#,c‡

37.0 ± 4.6

37.0 ± 5.0


36.8 ± 4.0

31.2 ± 5.1

38.3 ± 6.4


77.7 ± 6.6

77.1 ± 3.0

159.2 ± 7.6

110.4 ± 8.5

416.5 ± 33.0

361 ± 86.1


2.5 ± 0.4

2.5 ± 0.8

0.08 ± 0.3

0.8 ± 0.3



Weight (gram), AST and ALT, specific activities of aspartate amino transferase and alanine amino transferase, (Units per grams protein); TG, triacylglycerol (mg/dl); TC, total cholesterol (mg/dl); Total protein (g/dl); HbA1c, glycosylated hemoglobin (%); and NO, nitric oxide (μmol/dl), FBS, fasting blood sugar (mg/dl); Insulin (μg/l). Data are presented as mean ± SD. NA Insulin concentrations were considered undetectable, as the values were negative −0.76 ± 0.3 and −0.66 ± 0.4 for CS and TCS, respectively. i.p, intraperitoneal;* AST and ALT were adjusted by a division of Total protein values. acontrol vs. STZ; bchicory-control vs. STZ; cSTZ vs. chicory-STZ; dcontrol vs. chicory-STZ; echicory-control vs. chicory-STZ, fSTZ vs. NIA/STZ; p < 0.01; p < 0.05; Ŧp < 0.001; #p ≤ 0.05.

Nitric oxide determination

NO was measured by modified Griess reaction[25]. Briefly, serially diluted standards or deproteinated serum samples, 2% sulfanilamide in 1M HCl, 0.1% N-(1-Naphthyl)ethylenediamine in ddH2O, and then vanadium chloride solution (80 mg dissolved in 10 ml of 1M HCl) were mixed (50 μl of each) in the mentioned order in a 96-well plate. After 45 min of incubation at 37°C, optical density was determined at 450 nm by a microplate reader (2020 Anthos, Austria). NO concentrations in the samples were determined using a standard calibration curve. Deproteination of serum samples was accomplished by 3000 MWCO VIVASPIN filters from Sartorius (Germany).

Intraperitoneal glucose tolerance test (IPGTT)

Another set of rats (5 groups also named control, STZ, NIA/STZ, chicory-STZ, and chicory-NIA/STZ, consisting of 6 rats each and prepared as explained in section of experimental diabetes above) was subjected to IPGTT. A chicory-control group was not included in this section of the study due to insufficient Rat Insulin Elisa Kit. Briefly, after an overnight fast, FBS was measured in six normal rats (control). The rats were anaesthetized; glucose (2 g/body weight) together with lyophilized extract of chicory (125 mg/body weight) were dissolved in 30-units volume of normal saline and injected intraperitoneally. Blood glucose was determined every 30 minutes in a drop of blood from the tail; at the same time, whole blood (1ml, every 30 min) was taken from the heart and sera were prepared for insulin measurement. The same procedure was conducted on two other groups of rats, STZ and NIA/STZ, immediately after being made diabetic. Because blood analysis on day 10 showed similar trend in the changes of blood parameters as day 28, rats in groups chicory-STZ and chicory-NIA/STZ were treated with chicory extract for 10 days prior to IPGTT.

Statistical analysis

The collected data essentially involved a 6 × 6 repeated measures with treatment groups as between-subjects factors and days of study as within-subjects factors. Data for weight and FBS were summarized with mean ± SD. Linear mixed effects models (SAS PROC MIXED) were used as the primary tool for assessment followed by a post-hoc least significance difference (LSD) for pair wise comparisons. Minor imputation was done for missing values. We assumed the unstructured covariance matrix to carry out the analysis. Akaike's Information Criterion (AIC) and Schwarz' Bayesian Criterion (SBC) were used to determine the underlying covariance structure. According to AIC, the autoregressive (AR1) of order 1 was used to model the covariance structure of longitudinal measures on each rat in the linear mixed effect model. Data of the blood variables on days 28 were presented as mean ± SD.

For the analysis of the 120 minutes follow-up data on blood glucose and insulin, truncated polynomial spline basis terms were introduced to model the nonlinearity and change points seen in the longitudinal progression for these measures. The area under curve (AUC) was determined by Image J Software (NIH) and compared using Kruskal-Wallis Test (nonparametric ANOVA). A p-value lower than 0.05 was considered statistically significant.


Blood sugar after diabetes induction

Although non-fasting blood sugar was measured at time zero, it can be inferred from following the FBS of non-diabetic groups (control and chicory-control) that normal FBS is around 86.5 ± 7.17 to 87.64 ± 9.41 (Table 1). In late-stage diabetic rat groups (STZ and chicory-STZ), a single STZ injection increased FBS about 3.5-fold. When one STZ injection was followed by a single injection of niacinamide (NIA), rats developed a form of early stage diabetes mellitus and FBS increased nearly 1.8-fold in NIA/STZ and chicory-NIA/STZ groups.

Weekly measurement of body weight

During the 4-wk treatment with chicory, the weight in control and chicory-control groups increased significantly (about 13%) as a result of ordinary growing up. As shown in Figure 1, the weight loss was significant (12.5%) in STZ group and negligible in NIA/STZ group (4.5%). The mean weight remained nearly constant during the study time in chicory-STZ group (1.6% weight losses only). An overall comparison of the groups across all time points suggested that chicory helped prevent excessive weight loss in both early- and late-stage diabetes mellitus, yet it did not lead to a weight gain either since chicory extract administration to normal healthy rats did not encourage any increase in weight (chicory-control compared with control).
Figure 1
Figure 1

Mean weight by day for each group.

Chicory treatment prevented excessive weight loss in both late and early stage of diabetes according to an overall comparison STZ with chicory-STZ (one sided p < 0.05) and NIA/STZ with chicory-NIA/STZ (one sided p < 0.01) across all time points. Ŧ show statistically significant differences between both control and chicory-control with all other groups; *show significant difference between chicory-STZ and STZ-diabetic groups; †show significant differences between chicory-NIA/STZ and NIA/STZ. Treatment with chicory started on day 5 after STZ and STZ + NIA injections and lasted for 28 days, thus a total of 33 days of study.

Weekly measurements of FBS

FBS levels did not change in control and chicory-control groups during 4-wk study time. FBS increased drastically in STZ and moderately, but significantly, in NIA/STZ groups. Chicory treated groups, chicory-STZ and chicory-NIA/STZ, were able to resist excessive increases in FBS (Figure 2). An overall comparison of the groups across all time points indicated chicory’s ability to lower blood sugar in both severe and mild diabetic rats. Nonetheless, on the final day of study, FBS was still much higher in chicory-STZ (final day vs. initial day: p-value <0.0001).
Figure 2
Figure 2

Mean FBS by day for each group.

The level of FBS remained mainly unchanged for control and chicory-control groups, increased considerably in STZ and moderately in NIA/STZ diabetic rats. Treatment with chicory extract lowered fasting blood sugar level in STZ (late stage) and NIA/STZ (early stage) diabetic rats (one-sided p < 0.05 for STZ vs. chicory-STZ and NIA/STZ vs. chicory-NIA/STZ groups). Body weight was included as a covariate to reduce variability. Ŧ show statistically significant differences between both control and chicory-control with all other groups; *show significant difference between chicory-STZ and STZ-diabetic groups; † show significant differences between chicory-NIA/STZ and NIA/STZ. Treatment with chicory started on day 5 after STZ and STZ + NIA injections and lasted for 28 days, thus a total of 33 days of study.

Blood parameters at the end of 4-wk study time

The results are summarized in Table 2. In STZ-diabetic group, 4 wk after diabetes induction, significant increases in ALT, TG, TC, HbA1c, and FBS and a significant decrease in NO comprised the major complications. In chicory-STZ group, daily chicory administration for 28 days, led to improvement of conditions even though HbA1c and FBS were still higher than normal. In NIA/STZ, the main variations included slight increases in TG and TC. Over a 4 wk treatment with chicory extract, the value of TG decreased toward normal. Total cholesterol increased slightly further after treatment with chicory for 28 days despite a decrease on day 10 after treatment.


According to Table 2, the effects of chicory on FBS and Insulin were most obvious in NIA/STZ-diabetic rats. In NIA/STZ, the remaining beta cells of the pancreas were still producing some insulin, which despite being significantly lower than normal (control vs. NIA/STZ, p < 0.001) was keeping blood sugar concentration at around 150 mg/dl. After treatment with chicory, insulin levels increased in chicory-NIA/STZ (chicory-NIA/STZ vs. NIA/STZ, p < 0.001 without and p < 0.05 with adjustment for weight).

The mean plots for blood glucose and insulin demonstrate the progression patterns across different groups (Figure 3A and B). Blood glucose levels stayed high and insulin was undetectable in STZ and chicory-STZ groups during the 120-minute follow up. In chicory-NIA/STZ group, blood sugar values were lower and so close to control group that occasionally, at 30 and 90 min, the difference between control and chicory-NIA/STZ became insignificant statistically. However, according to AUC, total glucose showed a significant difference between control and NIA/STZ groups (P<0.001); but the AUCs for NIA/STZ and chicory-NIA/STZ groups were not significantly different (p>0.05).
Figure 3
Figure 3

IPGTT. Mean plots for blood glucose (A) and insulin (B) by time. (A) Blood glucose follow-up for 120 minutes. Blood sugar levels in NIA/STZ were statistically and significantly higher than control at all points in time during GTT (p < 0.0001). Chicory lowered blood sugar values closer to control. (Control vs. chicory-NIA/STZ: initial, p <0.0001; 30 min, p > 0.05; 60 min, p = 0.01; 90 min, p = 0.05; 120 min, p < 0.001. NIA/STZ vs. chicory-NIA/STZ: initial, p < 0.001; 30 min, p < 0.01; 60 min, p < 0.001; 90 min, p < 0.01; 120 min, p < 0.0001). (B) Blood insulin follow-up for 120 min. The timing of maximum insulin was 30 min, 60 min and 90 min for control, chicory-NIA/STZ, and NIA/STZ, respectively.

According to Figure 3B, there was a significant difference regarding the progression nonlinear patterns among Control, NIA/STZ, and chicory-NIA/STZ groups (p < 0.001). In terms of the change point analysis, it could be confirmed that Control had a peak or change point at min 30 (p < 0.0001); chicory-NIA/STZ had a change point at min 60 (p < 0.0001); and NIA/STZ had a peak or change point at min 90 (p < 0.001). AUC calculation for insulin showed that total insulin levels were not significantly different in three groups (Table 3).
Table 3

Area under curve (AUC) for glucose and insulin in Figure 3

Area Under Curve (AUC)







156524 ± 4099

178229 ± 6595

172765 ± 3354

195472 ± 2408

190161 ± 3828


128189 ±10450

143380 ± 7985

123864 ± 7024



AUC for glucose in control was significantly different than AUC for NIA/STZ (P<0.001). AUCs for insulin were not significantly different among the three groups, p > 0.05). NA, non applicable.


Early stage T2DM transformation to advance diabetes occurs over time and is due to gradual destruction of pancreatic β cells. As prevention is meant to inhibit an abnormal condition from getting worse or to delay the side effects of a disease, it seemed important to us to investigate the effects of chicory seed extract on early diabetes.


The effect of chicory extract on GTT was the main observation of this study, which is summarized in Figures 3A and B. The comparison of GTT plots for Control, NIA/STZ, and chicory-NIA/STZ groups may suggest a relative improvement of insulin sensitivity and a reduction of insulin resistance in the chicory-treated group (chicory-NIA/STZ) (Figure 3B). Hyperinsulinemia in NIA/STZ implies that peripheral tissue insulin resistance occurred after partial beta cell destruction, while the alleviation of hyperinsulinemia together with the alleviation of ALT activity in the chicory-treated group suggests an amelioration of insulin resistance[26]. The change in the peak insulin time point in chicory-NIA/STZ compared to NIA/STZ (60 min vs. 90 min) is an indication of a quicker response of the pancreatic beta cells to postprandial hyperglycemia and further supports chicory’s ability to stimulate insulin secretion form pancreatic beta cells. The same effects are not observed in chicory-STZ group presumably because of lack of insulin in advanced diabetes. It can be argued that chicory plays the role of an insulin-sensitizer and should also be able to act in late stage diabetic patients who receive exogenous insulin injections.

Blood parameters

Lack of insulin in chicory-STZ, however, did not stop chicory’s long-term positive effects on blood parameters. Deaths were prevented in chicory treated severe diabetes. The decrease in TG and TC in the blood of chicory-STZ rats may be secondary to improved lipid metabolism[27] and inhibition of adipogenesis[10]. In chicory-NIA/STZ rats, the increase in TC over 28 days of exposure to chicory extract may be due to an increase in HDL-cholesterol according to Kim and Shin[27].

In our study, NO levels were found to be low in the blood of diabetic rats. Several studies have shown that patients with Type 2 diabetes have decreased endothelial nitric oxide (eNO) production, and enhanced plasma concentrations of asymmetrical dimethylarginine (ADMA), an inhibitor that suppresses eNO synthesis and produces vascular dysfunction and neurological disorders[28]. As NO is also an important player in the nervous system, there may be a beneficial role of chicory in the prevention of both cardiovascular and neurological implications of diabetes, as it has been described for the aging myocardium of albino rats and oxidative defense system in the brain of diabetic rats[29, 30].

The rise in the activity of liver enzymes ALT and AST in blood is common in liver diseases; but several recent studies have suggested the circulating ALT levels at the upper range of normal limits and high ALT/AST ratios to be associated with high prevalence of metabolic syndrome, insulin resistance (IR) and obesity[26, 3133]. In this study, severe diabetes was accompanied by statistically significant increase in ALT specific activities that was lowered by chicory treatment, a confirmation of the hepatoprotective properties of chicory and improvement of metabolic syndrome and insulin resistance. AST specific activity and Total protein levels were sustained according to Table 2, the former implying higher ALT/AST ratios.

Glycosylated hemoglobin (HbA1c) that had almost doubled in STZ rats indicated some reduction in the chicory-treated late stage diabetes (chicory-STZ) meaning that blood sugar levels were kept at relatively lower levels under the influence of chicory extract. The observations related to blood parameters in severe diabetes suggest that chicory may be also capable to act through insulin-independent mechanisms.

Obesity is a risk factor for developing diabetes mellitus; but diabetes itself is accompanied by loss of weight due to muscle wasting. Diabetic patients suffer from negative nitrogen balance[34]. Chicory extract prevented weight loss in both severe and mild diabetes. Weight loss inhibition could be due to an easing of glucose transportation into the peripheral tissue as a result of possible correction of insulin resistance (in early diabetes) and improved lipid metabolism (in late stage diabetes); it cannot be ruled out, however, that chicory extract components may also have further effects directly on protein metabolism[35].

Unlike the bitter taste of chicory leaves and roots, chicory seed decoction is palatable. Although many studies have used alcoholic extract of chicory, homemade preparations are usually made in water, as alcohol is both toxic to the liver and prohibited in many cultures. The glucose lowering capacity of chicory has been attributed to its chemical composition including antioxidant compounds[17], anthocyanins[36], tannins[10], coumarins, chicoric acid, chlorogenic acid, and caffeic acid[37]. The role of antioxidants in the management of diabetes and its complications has been reviewed[38]. Chicory possesses a strong antioxidant capacity; for the aqueous seed extract used in this study, 1, 1-diphenyl-2-picryl hydrazyl radical (DPPH)-50% inhibition (IC50) was calculated to be 180.5 μg/ml by DPPH radical-scavenging assay[39]. Chicory contains vitamins and many of the essential amino acids, and carbohydrates[9]. The effects of chicory seed extract observed in this study are despite the presence of sugar in the extract (total of approximately 183.7 mg soluble sugar per g dry weight of stock powder, measured by Kochert method[40]). The sugar in the seed extract includes sucrose, and an oligosaccharide which was shown by chromatographic analysis to consist of glucose and fructose (data not shown). The quantity of glucose, fructose and sucrose has been measured by Jurgonskiet al[41]; they also examined water-soluble and lipid-soluble fractions of chicory peel and seed extract for antioxidant capacity and their effects on the activities of superoxide dismutase and glutathione peroxidase enzymes[18, 41].


The results of the present study suggest that chicory may exert both short- and long-term effects on diabetes, the former being under the influence of insulin and through its insulin-sensitizing action. The long-term beneficial effects of chicory may arise without the assistance of insulin.



Tehran University of Medical Sciences and Health Services financially supported this research under Grant No10503. We thank Mehdi Gholami of the School of Pharmacy, Animal Lab, for his assistance with animal care and handling, and the Pathology Laboratory of Shariati Hospital in Tehran for their aid in blood biochemistry measurements. This article is the product of MSc thesis of the first author.

Authors’ Affiliations

Department of Biochemistry, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
Faculty of Pharmacy, and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran
University of Alabama School of Nursing, University of Alabama at Birmingham, Birmingham, AL, USA
Department of Physiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
Department of Clinical Laboratory Sciences, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran


  1. Ansari G, Mojtahedzadeh M, Kajbaf F, Najafi A, Khajavi M, Khalili H, Ahmadi H, Abdollahi M: How does blood glucose control with metformin influence intensive insulin protocols? Evidence for involvement of oxidative stress and inflammatory cytokines. Adv Ther. 2008, 25: 681-702. 10.1007/s12325-008-0075-1.View ArticlePubMedGoogle Scholar
  2. Rains JL, Jain SK: Oxidative stress, insulin signaling, and diabetes. Free Radical Bio Med. 2011, 50: 567-575. 10.1016/j.freeradbiomed.2010.12.006.View ArticleGoogle Scholar
  3. Rioux CL: Traffic exposure in a population with high prevalence Type 2 diabetes-Do medications influence concentrations of C-reactive protein?. Environ Pollut. 2011, 159: 2051-2060. 10.1016/j.envpol.2010.12.025.PubMed CentralView ArticlePubMedGoogle Scholar
  4. Sothern MS: Obesity prevention in children: physical activity and nutrition. Nutrition. 2004, 20: 704-708. 10.1016/j.nut.2004.04.007.View ArticlePubMedGoogle Scholar
  5. Barker DJ: The origins of the developmental origins theory. J Intern Med. 2007, 261: 412-417. 10.1111/j.1365-2796.2007.01809.x.View ArticlePubMedGoogle Scholar
  6. Mojtahedzadeh M, Rouini MR, Kajbaf F, Najafi A, Gholipour A, Mofid AR, Abdollahi M: Advantage of adjunct metformin and insulin therapy in the management of glycemia in critically ill patients. Evidence for nonoccurrence of lactic acidosis and needing to parenteral metformin. Arch Med Sci. 2008, 4: 174-181.Google Scholar
  7. Li Y, Huang TH, Yamahara J: Salacia root, a unique Ayurvedic medicine, meets multiple targets in diabetes and obesity. Life Sci. 2008, 82: 1045-1049. 10.1016/j.lfs.2008.03.005.View ArticlePubMedGoogle Scholar
  8. Liu Q, Chen L, Hu L, Guo Y, Shen X: Small molecules from natural sources, targeting signaling pathways in diabetes. Biochim Biophys Acta. 2010, 1799: 854-865. 10.1016/j.bbagrm.2010.06.004.View ArticlePubMedGoogle Scholar
  9. Mares D, Romagnoli C, Tosi B, Andreotti E, Chillemi G, Poli F: Chicory extracts from Cichorium intybus L. as potential antifungals. Mycopathologia. 2005, 160: 85-91. 10.1007/s11046-004-6635-2.View ArticlePubMedGoogle Scholar
  10. Muthusamy VS, Anand S, Sangeetha KN, Sujatha S, Arun B, Lakshmi BS: Tannins present in Cichorium intybus enhance glucose uptake and inhibit adipogenesis in 3T3-L1 adipocytes through PTP1B inhibition. Chem Biol Interact. 2008, 174: 69-78. 10.1016/j.cbi.2008.04.016.View ArticlePubMedGoogle Scholar
  11. Jamshidzadeh A, Khoshnood MJ, Dehghani Z, Niknahad H: Hepatoprotective activity of Cichorium intybus L. leaves extract against tetrachloride induced toxicity. IJPR. 2006, 5: 41-46.Google Scholar
  12. Pushparaj PN, Low HK, Manikandan J, Tan BK, Tan CH: Anti-diabetic effects of Cichorium intybus in streptozotocin-induced diabetic rats. J Ethnopharmacol. 2007, 111: 430-434. 10.1016/j.jep.2006.11.028.View ArticlePubMedGoogle Scholar
  13. Tousch D, Lajoix AD, Hosy E, Azay-Milhau J, Ferrare K, Jahannault C, Cros G, Petit P: Chicoric acid, a new compound able to enhance insulin release and glucose uptake. Biochem Biophys Res Commun. 2008, 377: 131-135. 10.1016/j.bbrc.2008.09.088.View ArticlePubMedGoogle Scholar
  14. Zafar R, Mujahid AS: Anti-hepatotoxic effects of root and root callus extracts of Cichorium intybus L. J Ethnopharmacol. 1998, 63: 227-231. 10.1016/S0378-8741(98)00087-7.View ArticlePubMedGoogle Scholar
  15. Ahmed B, Al-Howiriny TA, Siddiqui AB: Antihepatotoxic activity of seeds of Cichorium intybus. J Ethnopharmacol. 2003, 87: 237-240. 10.1016/S0378-8741(03)00145-4.View ArticlePubMedGoogle Scholar
  16. Ahmed NZ MDK, Ahmed MM: Studies on Curcuma longa, Chicorium intybus and Petroselinum sativum water extracts against cisplatin-induced toxicity in rats. J Am Sci. 2010, 6: 545-558.Google Scholar
  17. Hassan HA, Yousef MI: Ameliorating effect of chicory (Cichorium intybus L.)-supplemented diet against nitrosamine precursors-induced liver injury and oxidative stress in male rats. Food Chem Toxicol. 2010, 48: 2163-2169. 10.1016/j.fct.2010.05.023.View ArticlePubMedGoogle Scholar
  18. Jurgonski A, Juskiewicz J, Zdunczyk Z, Krol B: Caffeoylquinic acid-rich extract from chicory seeds improves glycemia, atherogenic index, and antioxidant status in rats. Nutrition. 2012, 28: 300-306. 10.1016/j.nut.2011.06.010.View ArticlePubMedGoogle Scholar
  19. Al-Wabel NA, Mousa HM, Omer OH, Abdel-Salam AM: Biological evaluation of aqueous herbal extracts and stirred yoghurt filtrate mixture against alloxane-induced oxidative stress and diabetes in rats. Int J Pharmacol. 2008, 4: 135-139. 10.3923/ijp.2008.135.139.View ArticleGoogle Scholar
  20. Nowrouzi A, Vardasbi S, Shajary Z, Tonekaboni MS, Ziamajidi N, Ghamarian A, Zakeri R, Bushehri H, Golestani A, Khaghani SH, Ansari M: Glucose lowering and hepatotoxic effects of Cichorium intybus extracts. JICS. 2009, 6: S143-Google Scholar
  21. Broca C, Gross R, Petit P, Sauvaire Y, Manteghetti M, Tournier M, Masiello P, Gomis R, Ribes G: 4-Hydroxyisoleucine: experimental evidence of its insulinotropic and antidiabetic properties. Am J Physiol. 1999, 277: E617-E623.PubMedGoogle Scholar
  22. Chen CW, Cheng HH: A rice bran oil diet increases LDL-receptor and HMG-CoA reductase mRNA expressions and insulin sensitivity in rats with streptozotocin/nicotinamide-induced Type 2 diabetes. J Nutr. 2006, 136: 1472-1476.PubMedGoogle Scholar
  23. Su HC, Hung LM, Chen JK: Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats. Am J Physiol-Endoc M. 2006, 290: E1339-E1346.Google Scholar
  24. Masiello P, Broca C, Gross R, Roye M, Manteghetti M, Hillaire-Buys D, Novelli M, Ribes G: Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes. 1998, 47: 224-229. 10.2337/diabetes.47.2.224.View ArticlePubMedGoogle Scholar
  25. Nagi MN, Almakki HA, Sayed-Ahmed MM, Al-Bekairi AM: Thymoquinone supplementation reverses acetaminophen-induced oxidative stress, nitric oxide production and energy decline in mice liver. Food Chem Toxicol. 2010, 48: 2361-2365. 10.1016/j.fct.2010.05.072.View ArticlePubMedGoogle Scholar
  26. Zhang Y, Lu X, Hong J, Chao M, Gu W, Wang W, Ning G: Positive correlations of liver enzymes with metabolic syndrome including insulin resistance in newly diagnosed Type 2 diabetes mellitus. Endocrine. 2010, 38: 181-187. 10.1007/s12020-010-9369-6.View ArticlePubMedGoogle Scholar
  27. Kim M, Shin HK: The water-soluble extract of chicory influences serum and liver lipid concentrations, cecal short-chain fatty acid concentrations and fecal lipid excretion in rats. J Nutr. 1998, 128: 1731-1736.PubMedGoogle Scholar
  28. Das UN: Hypothesis: intensive insulin therapy-induced mortality is due to excessive serotonin autoinhibition and autonomic dysregulation. World J Diabetes. 2010, 1: 101-108. 10.4239/wjd.v1.i4.101.PubMed CentralView ArticlePubMedGoogle Scholar
  29. Nayeemunnisa A: Alloxan diabetes-induced oxidative stress and impairment of oxidative defense system in rat brain: neuroprotective effects of Cichorium intybus. Int J Diabet Metab. 2009, 17: 105-109.Google Scholar
  30. Nayeemunnisa A, Rani MK: Cardioprotective effects of Cichorium intybus in ageing myocardium of albino rats. Curr Sci India. 2003, 84: 941-943.Google Scholar
  31. Mojiminiyi OA, Abdella NA, Al Mohammedi H: Higher levels of alanine aminotransferase within the reference range predict unhealthy metabolic phenotypes of obesity in normoglycemic first-degree relatives of patients with Type 2 diabetes mellitus. J Clin Hypertens. 2010, 12: 301-308. 10.1111/j.1751-7176.2009.00238.x.View ArticleGoogle Scholar
  32. Rothbaum Perito EJ, Lustig RH, Bass NM: Alanine aminotransferase (ALT) elevation in obese children and adolescents: a predictor of insulin resistance and possible precursor to metabolic syndrome. Gastroenterology. 2011, 140: S-892.Google Scholar
  33. Ohgo H, Yokoyama H, Hirose H, Kawabe H, Saito I, Tomita K, Hibi T: Significance of ALT/AST ratio for specifying subjects with metabolic syndrome in its silent stage. Diabetest Metab Syndr. 2009, 3: 3-6. 10.1016/j.dsx.2008.10.001.View ArticleGoogle Scholar
  34. Kaleem M, Medha P, Ahmed QU, Asif M, Bano B: Beneficial effects of Annona squamosa extract in streptozotocin-induced diabetic rats. Singapore Med J. 2008, 49: 800-804.PubMedGoogle Scholar
  35. Nayeemunnisa A, Nawaz R, Jayashree C: Changes in the original protein metabolism in the central nervous system (CNS) of diabetic rat: protection by Cichorium intybus (Chicory). Phcog mag. 2006, 2: 130-132.Google Scholar
  36. Norbaek R, Nielsen K, Kondo T: Anthocyanins from flowers of Cichorium intybus. Phytochemistry. 2002, 60: 357-359. 10.1016/S0031-9422(02)00055-9.View ArticlePubMedGoogle Scholar
  37. Chkhikvishvili ID, Kharebava GI: Chicoric and chlorogenic acids in various plants growing in Georgia. Prikl Biokhim Mikrobiol. 2001, 37: 214-217.PubMedGoogle Scholar
  38. Rahimi R, Nikfar S, Larijani B, Abdollahi M: A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother. 2005, 59: 365-373. 10.1016/j.biopha.2005.07.002.View ArticlePubMedGoogle Scholar
  39. Samarth RM, Panwar M, Kumar M, Soni A, Kumar M, Kumar A: Evaluation of antioxidant and radical-scavenging activities of certain radioprotective plant extracts. Food Chem. 2008, 106: 868-873. 10.1016/j.foodchem.2007.05.005.View ArticleGoogle Scholar
  40. Kochert G: Carbohydrate determination by the phenolsulfuric acid method. Handbook of Physiology Methods, Physiological and Biochemical Methods. Edited by: Hellebust JA, Craigie JS. 1978, Cambridge University Press, Cambridge, 95-97.Google Scholar
  41. Jurgonski A, Milala J, Juskiewicz J, Kerol B: Composition of chicory root, peel, seed and leaf ethanol extracts and biological properties of their non-insulin fractions. Food Technol Biotech. 2011, 49: 40-47.Google Scholar


© Ghamarian et al.; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.